Targeting metabolic reprogramming in persister cancer cells: Emerging insights and therapeutic opportunities.
ABSTRACT Persister cancer cells (PCCs) constitute a transient tumor subpopulation that survives anticancer therapy by entering a drug-tolerant state, characterized by enhanced stress resilience and profound metabolic adaptation. Unlike genetically resistant clones, PCCs rely on reversible metabolic adaptations centrall...